Experienced in Coronary Artery Bypass Graft (CABG)

Dr. Mark Russo

Thoracic Surgery
Rutgers - Robert Wood Johnson Medical School
125 Paterson St Ste 4100, 
New Brunswick, NJ 
Clinical Trials:Currently Recruiting for 3 Trials
Offers Telehealth
Experienced in Coronary Artery Bypass Graft (CABG)
Rutgers - Robert Wood Johnson Medical School
125 Paterson St Ste 4100, 
New Brunswick, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Russo is a Thoracic Surgeon in New Brunswick, New Jersey. Dr. Russo is rated as an Experienced provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Aortic Valve Stenosis, Aortic Regurgitation, Mitral Valve Regurgitation, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 162 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Coronary Artery Bypass Graft (CABG).

Specialties
Thoracic Surgery
Licenses
Specialist in NY
Hospital Affiliations
Robert Wood Johnson University Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Rutgers - Robert Wood Johnson Medical School
125 Paterson St Ste 4100, New Brunswick, NJ 08901
Other Locations
RWJ University Hospital New Brunswick
1 Robert Wood Johnson Pl Ste 512, New Brunswick, NJ 08901

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: May 21, 2025
Intervention Type: Device
Study Phase: Not Applicable
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Percutaneous MitraClip Device or Surgical Mitral Valve REpair in PAtients With PrImaRy MItral Regurgitation Who Are Candidates for Surgery (REPAIR MR)
Enrollment Status: Recruiting
Publish Date: May 01, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Device
Study Phase: Not Applicable
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 20, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: November 29, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: November 18, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active_not_recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

162 Total Publications

Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
Journal: European heart journal
Published: July 07, 2025
Similar Doctors
John Puskas
Elite in Coronary Artery Bypass Graft (CABG)
Dr. John Puskas
Thoracic Surgery
Elite in Coronary Artery Bypass Graft (CABG)
Dr. John Puskas
Thoracic Surgery

Mount Sinai St. Luke's

1111 Amsterdam Ave # C, 
New York, NY 
 (32.9 miles away)
212-257-0031
Experience:
40+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Puskas is a Thoracic Surgeon in New York, New York. Dr. Puskas has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Congenital Coronary Artery Malformation, Heart Tumor, Atrial Myxoma, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Elite in Coronary Artery Bypass Graft (CABG)
Dr. Francis Sutter
Thoracic Surgery
Elite in Coronary Artery Bypass Graft (CABG)
Dr. Francis Sutter
Thoracic Surgery

Lankenau Medical Center

100 E Lancaster Ave, 
Wynnewood, PA 
 (55.3 miles away)
484-476-1000
Languages Spoken:
English
See accepted insurances

Francis Sutter is a Thoracic Surgeon in Wynnewood, Pennsylvania. Dr. Sutter is rated as a Distinguished provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Arterial Embolism, Pleurisy, Carotid Artery Disease, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Elite in Coronary Artery Bypass Graft (CABG)
Dr. Gianluca Torregrossa
Thoracic Surgery
Elite in Coronary Artery Bypass Graft (CABG)
Dr. Gianluca Torregrossa
Thoracic Surgery

Lankenau Medical Center

100 E Lancaster Ave, 
Wynnewood, PA 
 (55.3 miles away)
484-476-1000
Languages Spoken:
English
See accepted insurances

Gianluca Torregrossa is a Thoracic Surgeon in Wynnewood, Pennsylvania. Dr. Torregrossa is rated as a Distinguished provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Aortic Dissection, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Russo's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile